Arcutis Biotherapeutics, Inc (ARQT) insider trading
Every open-market stock purchase and sale by Arcutis Biotherapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Terrie Curran (Director) and 4 others sold $2.3M in the last 90 days.
- Last insider buy: Patrick J Heron (Insider), $34.6K, 16 months ago.
- Congress: Gilbert Cisneros bought $1K to $15K, 5 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $16.3M (55 sales). Last close $31.87 on Oct 21, 2026.
Recent ARQT insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 15, 2026 | Howard G. Welgus (Director) | Sold | $127K |
| Oct 15, 2026 | Howard G. Welgus (Director) | Bought (not open market) | $19.5K |
| Oct 15, 2026 | Howard G. Welgus (Director) | Bought (not open market) | $7.6K |
| Oct 15, 2026 | Howard G. Welgus (Director) | Bought (not open market) | $5.4K |
| Oct 15, 2026 | Howard G. Welgus (Director) | Bought (not open market) | — |
| Oct 15, 2026 | Howard G. Welgus (Director) | Bought (not open market) | — |
| Oct 15, 2026 | Howard G. Welgus (Director) | Bought (not open market) | — |
| Sep 16, 2026 | Masaru Matsuda (Officer) | Sold | $91.9K |
| Sep 15, 2026 | Howard G. Welgus (Director) | Sold | $114K |
| Sep 15, 2026 | Howard G. Welgus (Director) | Bought (not open market) | $19.5K |
| Sep 15, 2026 | Howard G. Welgus (Director) | Bought (not open market) | $7.7K |
| Sep 15, 2026 | Howard G. Welgus (Director) | Bought (not open market) | $5.4K |
| Sep 15, 2026 | Howard G. Welgus (Director) | Bought (not open market) | — |
| Sep 15, 2026 | Howard G. Welgus (Director) | Bought (not open market) | — |
| Sep 15, 2026 | Howard G. Welgus (Director) | Bought (not open market) | — |
| Sep 8, 2026 | Masaru Matsuda (Officer) | Sold | $250K |
| Aug 27, 2026 | Terrie Curran (Director) | Sold | $677K |
| Aug 27, 2026 | Terrie Curran (Director) | Sold | $279K |
| Aug 27, 2026 | Terrie Curran (Director) | Bought (not open market) | $233K |
| Aug 27, 2026 | Terrie Curran (Director) | Bought (not open market) | $83.7K |
| Aug 27, 2026 | Terrie Curran (Director) | Bought (not open market) | — |
| Aug 27, 2026 | Terrie Curran (Director) | Bought (not open market) | — |
| Aug 20, 2026 | Terrie Curran (Director) | Sold | $27.9K |
| Aug 20, 2026 | Terrie Curran (Director) | Bought (not open market) | $8.1K |
| Aug 20, 2026 | Terrie Curran (Director) | Bought (not open market) | — |
Who's trading ARQT
- Howard G. Welgus, Director: sold $2.4M (13 sales), last Oct 15, 2026
- Masaru Matsuda, Officer: sold $2.2M (18 sales), last Sep 16, 2026
- Terrie Curran, Director: sold $984K (3 sales), last Aug 27, 2026
- Patrick Burnett, Officer: sold $2M (18 sales), last Aug 19, 2026
- Todd Watanabe, Officer: sold $4.4M (10 sales), last Aug 3, 2026
- Christopher Peetz, Director: other filings, last Jul 15, 2026
- Sue-Jean Lin, Director: sold $899K (2 sales), last Jun 15, 2026
- Amit Munshi, Director: other filings, last Jun 5, 2026
- Keith R Leonard, Director: sold $997K (1 sale), last Jun 5, 2026
- Neha Krishnamohan, Director: sold $939K (2 sales), last Jun 5, 2026
- Halley E Gilbert, Director: sold $455K (1 sale), last Jun 5, 2026
- Patrick J Heron, Insider: other filings, last Jun 5, 2026
- Gilbert Cisneros, Representative: bought $16K (2 buys), sold $8K (1 sale), last May 29, 2026
- Latha Vairavan, CFO: sold $148K (6 sales), last May 11, 2026
- Larry Todd Edwards, Officer: sold $878K (4 sales), last Mar 2, 2026
Get free alerts when an insider at Arcutis Biotherapeutics, Inc files a new trade →